BCWM
DNA icon

Bartlett & Co Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Bartlett & Co Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119 Hold
12
– – ﹤0.01% 1257
2025
Q4 		$100 Hold
12
– – ﹤0.01% 1215
2025
Q3 		$175 Hold
12
– – ﹤0.01% 1168
2025
Q2 		$135 Hold
12
– – ﹤0.01% 1217
2025
Q1 		$68 Hold
12
– – ﹤0.01% 1217
2024
Q4 		$118 Hold
12
– – ﹤0.01% 1109
2024
Q3 		$98 Sell
12
-1
-8% -$10 ﹤0.01% 1112
2024
Q2 		$167 Sell
13
-7
-35% -$209 ﹤0.01% 1115
2024
Q1 		$928 Hold
20
– – ﹤0.01% 1072
2023
Q4 		$1.42K Hold
20
– – ﹤0.01% 1175
2023
Q3 		$1.45K Buy
20
+7
+54% +$560 ﹤0.01% 1096
2023
Q2 		$930 Hold
13
– – ﹤0.01% 1105
2023
Q1 		$665 Buy
+13
New +$824 ﹤0.01% 1026

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return